Suchergebnisse - "Salvatierra, Juan"

PubPharm (4)

1

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab : comment

enthalten in: Reumatologia clinica | 2023

von Aomar-Millán, I. | Salvatierra, J. | Callejas-Rubio, J. | +1

2

Characteristics and clinical outcome in 312 patients with moderate to severe pneumonia due to SARS-COV-2 and hyperinflammation treated with anakinra and corticosteroids : A retrospective cohort study

enthalten in: PloS one | 2023

von Aomar-Millán, I. | de Victoria-Carazo, J. | Fernández Reyes, D. | +8

3

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study : reply

enthalten in: Internal and emergency medicine | 2021

von Aomar-Millán, I. | Salvatierra, J. | Hernández-Quero, J.

CommentOn: Intern Emerg Med. 2021 Jun;16(4):1101-1103. - PMID 33598871

4

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study

enthalten in: Internal and emergency medicine | 2021

von Aomar-Millán, I. | Salvatierra, J. | Torres-Parejo, �. | +7

CommentIn: Intern Emerg Med. 2021 Jun;16(4):1101-1103. - PMID 33598871

1
[1]